These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8494898)

  • 21. Putative folding pathway of insulin-like growth factor-I.
    Rosenfeld RD; Miller JA; Narhi LO; Hawkins N; Katta V; Lauren S; Weiss MA; Arakawa T
    Arch Biochem Biophys; 1997 Jun; 342(2):298-305. PubMed ID: 9186491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The sequence determinant causing different folding behaviors of insulin and insulin-like growth factor-1.
    Huang QL; Zhao J; Tang YH; Shao SQ; Xu GJ; Feng YM
    Biochemistry; 2007 Jan; 46(1):218-24. PubMed ID: 17198392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of an alternative disulfide bond on the structure, stability, and folding of human lysozyme.
    Arai M; Hamel P; Kanaya E; Inaka K; Miki K; Kikuchi M; Kuwajima K
    Biochemistry; 2000 Mar; 39(12):3472-9. PubMed ID: 10727242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human gene 2 relaxin chain combination and folding.
    Tang JG; Wang ZH; Tregear GW; Wade JD
    Biochemistry; 2003 Mar; 42(9):2731-9. PubMed ID: 12614168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of individual disulfide bonds in the stability and folding of an omega-conotoxin.
    Price-Carter M; Hull MS; Goldenberg DP
    Biochemistry; 1998 Jul; 37(27):9851-61. PubMed ID: 9657699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chiral mutagenesis of insulin. Foldability and function are inversely regulated by a stereospecific switch in the B chain.
    Nakagawa SH; Zhao M; Hua QX; Hu SQ; Wan ZL; Jia W; Weiss MA
    Biochemistry; 2005 Apr; 44(13):4984-99. PubMed ID: 15794637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The folding process of acylphosphatase from Escherichia coli is remarkably accelerated by the presence of a disulfide bond.
    Parrini C; Bemporad F; Baroncelli A; Gianni S; Travaglini-Allocatelli C; Kohn JE; Ramazzotti M; Chiti F; Taddei N
    J Mol Biol; 2008 Jun; 379(5):1107-18. PubMed ID: 18495159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequences of B-chain/domain 1-10/1-9 of insulin and insulin-like growth factor 1 determine their different folding behavior.
    Chen Y; You Y; Jin R; Guo ZY; Feng YM
    Biochemistry; 2004 Jul; 43(28):9225-33. PubMed ID: 15248780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refolding and oxidation of recombinant human stem cell factor produced in Escherichia coli.
    Jones MD; Narhi LO; Chang WC; Lu HS
    J Biol Chem; 1996 May; 271(19):11301-8. PubMed ID: 8626682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete folding of bovine pancreatic trypsin inhibitor with only a single disulfide bond.
    Staley JP; Kim PS
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1519-23. PubMed ID: 1371875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide models of four possible insulin folding intermediates with two disulfides.
    Jia XY; Guo ZY; Wang Y; Xu Y; Duan SS; Feng YM
    Protein Sci; 2003 Nov; 12(11):2412-9. PubMed ID: 14573855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competition between DsbA-mediated oxidation and conformational folding of RTEM1 beta-lactamase.
    Frech C; Wunderlich M; Glockshuber R; Schmid FX
    Biochemistry; 1996 Sep; 35(35):11386-95. PubMed ID: 8784194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of residue B5 to the folding and function of insulin and IGF-I: constraints and fine-tuning in the evolution of a protein family.
    Sohma Y; Hua QX; Liu M; Phillips NB; Hu SQ; Whittaker J; Whittaker LJ; Ng A; Roberts CT; Arvan P; Kent SB; Weiss MA
    J Biol Chem; 2010 Feb; 285(7):5040-55. PubMed ID: 19959476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing the folding pathways of long R(3) insulin-like growth factor-I (LR(3)IGF-I) and IGF-I via capture and identification of disulfide intermediates by cyanylation methodology and mass spectrometry.
    Yang Y; Wu J; Watson JT
    J Biol Chem; 1999 Dec; 274(53):37598-604. PubMed ID: 10608814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of disulfide bridges in the folding, structure and biological activity of omega-conotoxin GVIA.
    Flinn JP; Pallaghy PK; Lew MJ; Murphy R; Angus JA; Norton RS
    Biochim Biophys Acta; 1999 Sep; 1434(1):177-90. PubMed ID: 10556572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the Cys 2-Cys 10 disulfide bond for the structure, stability, and folding kinetics of ribonuclease T1.
    Mayr LM; Willbold D; Landt O; Schmid FX
    Protein Sci; 1994 Feb; 3(2):227-39. PubMed ID: 8003959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro refolding/unfolding pathways of amphioxus insulin-like peptide: implications for folding behavior of insulin family proteins.
    Chen Y; Jin R; Dong HY; Feng YM
    J Biol Chem; 2004 Dec; 279(53):55224-33. PubMed ID: 15501824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of disulfide bonds in folding and activity of leiurotoxin I: just two disulfides suffice.
    Zhu Q; Liang S; Martin L; Gasparini S; Ménez A; Vita C
    Biochemistry; 2002 Sep; 41(38):11488-94. PubMed ID: 12234192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unfolding and refolding pathways of a major kinetic trap in the oxidative folding of alpha-lactalbumin.
    Salamanca S; Chang JY
    Biochemistry; 2005 Jan; 44(2):744-50. PubMed ID: 15641801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designing out disulfide bonds of leech carboxypeptidase inhibitor: implications for its folding, stability and function.
    Arolas JL; Castillo V; Bronsoms S; Aviles FX; Ventura S
    J Mol Biol; 2009 Sep; 392(2):529-46. PubMed ID: 19559710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.